• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿型肌肉糖原贮积病:磷酸葡萄糖变位酶缺乏伴肌肉和血清肉碱水平降低。

Infantile muscle glycogen storage disease: phosphoglucomutase deficiency with decreased muscle and serum carnitine levels.

作者信息

Sugie H, Kobayashi J, Sugie Y, Ichimura M, Miyamoto R, Ito T, Shimizu K, Igarashi Y

机构信息

Department of Pediatrics, Hamamatsu University School of Medicine, Japan.

出版信息

Neurology. 1988 Apr;38(4):602-5. doi: 10.1212/wnl.38.4.602.

DOI:10.1212/wnl.38.4.602
PMID:2965317
Abstract

We report a 5-month-old boy with recurrent vomiting, lethargy, and poor weight gain. He had profound metabolic acidosis and nonketotic dicarboxylic aciduria. The serum and muscle carnitine levels were significantly low (60% and 10% of the control means, respectively), suggesting that the patient had a systemic carnitine deficiency syndrome. The patient showed apparent clinical improvement on oral carnitine administration. A quadriceps muscle biopsy revealed a slight increase in intrafiber lipid droplets and mild accumulation of glycogen in the subsarcolemmal portion. An anaerobic glycolysis in vitro study showed a block after glucose-1-phosphate and before glucose-6-phosphate. Direct measurement of individual glycolytic enzymes in muscle of the patient demonstrated a marked decrease in phosphoglucomutase (PGM) activity (13% of the control mean). The specific defect of PGM activity in this patient suggests that the block in the anaerobic glycolytic pathway is the primary abnormality. PGM deficiency can be added as a newly recognized cause of secondary systemic carnitine deficiency syndromes.

摘要

我们报告了一名5个月大的男婴,有反复呕吐、嗜睡和体重增加缓慢的症状。他患有严重的代谢性酸中毒和非酮症性二羧酸尿症。血清和肌肉肉碱水平显著降低(分别为对照平均值的60%和10%),提示该患者患有全身性肉碱缺乏综合征。口服肉碱后,患者的临床症状明显改善。股四头肌活检显示肌纤维内脂质小滴略有增加,肌膜下部分糖原轻度积聚。体外无氧糖酵解研究显示,在1-磷酸葡萄糖之后、6-磷酸葡萄糖之前出现阻断。对该患者肌肉中各个糖酵解酶的直接测量表明,磷酸葡萄糖变位酶(PGM)活性显著降低(为对照平均值的13%)。该患者PGM活性的特定缺陷表明,无氧糖酵解途径的阻断是主要异常。PGM缺乏可作为继发性全身性肉碱缺乏综合征的一个新发现的病因。

相似文献

1
Infantile muscle glycogen storage disease: phosphoglucomutase deficiency with decreased muscle and serum carnitine levels.婴儿型肌肉糖原贮积病:磷酸葡萄糖变位酶缺乏伴肌肉和血清肉碱水平降低。
Neurology. 1988 Apr;38(4):602-5. doi: 10.1212/wnl.38.4.602.
2
[A case of adult onset phosphoglucomutase deficiency].
Rinsho Shinkeigaku. 1992 Jan;32(1):42-7.
3
[A case of phosphoglucomutase deficiency with decreased muscle and serum carnitine].
No To Hattatsu. 1986 Jul;18(4):310-5.
4
Glycogen storage disease with normal acid maltase: skeletal and cardiac muscles.酸性麦芽糖酶正常的糖原贮积病:骨骼肌和心肌
Pediatr Neurol. 1989 Jan-Feb;5(1):60-3. doi: 10.1016/0887-8994(89)90012-x.
5
[Biochemical analysis using biopsied muscle in 72 patients with metabolic myopathies].
Rinsho Shinkeigaku. 1989 May;29(5):584-7.
6
Fatal infantile form of muscle phosphofructokinase deficiency.肌肉磷酸果糖激酶缺乏症的致命婴儿型
Neurology. 1986 Nov;36(11):1465-70. doi: 10.1212/wnl.36.11.1465.
7
[Clinical, morphological and biochemical studies on muscle carnitine deficiency (author's transl)].关于肌肉肉碱缺乏症的临床、形态学及生物化学研究(作者译)
Klin Wochenschr. 1979 Sep 17;57(18):927-36. doi: 10.1007/BF01478549.
8
Fatal infantile glycogen storage disease: deficiency of phosphofructokinase and phosphorylase b kinase.致命性婴儿糖原贮积病:磷酸果糖激酶和磷酸化酶b激酶缺乏症
Neurology. 1981 Oct;31(10):1303-7. doi: 10.1212/wnl.31.10.1303.
9
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features.全身性肉碱缺乏综合征。临床、形态学、生化及病理生理学特征。
Neurology. 1975 Jan;25(1):16-24. doi: 10.1212/wnl.25.1.16.
10
Successful carnitine treatment in a non-carnitine-deficient lipid storage myopathy.非肉碱缺乏型脂质贮积性肌病中肉碱治疗成功的案例
Eur J Pediatr. 1980 Dec;135(2):205-9. doi: 10.1007/BF00441643.

引用本文的文献

1
Complex Metabolomic Changes in a Combined Defect of Glycosylation and Oxidative Phosphorylation in a Patient with Pathogenic Variants in and .一名同时存在糖基化和氧化磷酸化联合缺陷且 和 存在致病变异的患者的复杂代谢组学变化
Cells. 2025 Apr 25;14(9):638. doi: 10.3390/cells14090638.
2
Outcome of creatine supplementation therapy in phosphoglucomutase-1 deficiency associated congenital disorders of glycosylation: Novel insights.磷酸葡萄糖变位酶-1缺乏相关先天性糖基化障碍中补充肌酸治疗的结果:新见解
Mol Genet Metab Rep. 2025 Apr 3;43:101212. doi: 10.1016/j.ymgmr.2025.101212. eCollection 2025 Jun.
3
International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.
国际磷酸葡萄糖变位酶 1 缺乏症(PGM1-CDG)共识指南:诊断、随访和管理。
J Inherit Metab Dis. 2021 Jan;44(1):148-163. doi: 10.1002/jimd.12286. Epub 2020 Sep 15.
4
Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG.磷酸葡糖变位酶-1 缺乏症的半乳糖补充治疗;一种新型可治疗的 CDG 的综述与展望。
Mol Genet Metab. 2014 Aug;112(4):275-9. doi: 10.1016/j.ymgme.2014.06.002. Epub 2014 Jun 21.
5
Multiple phenotypes in phosphoglucomutase 1 deficiency.磷酸葡糖变位酶 1 缺乏症的多种表型。
N Engl J Med. 2014 Feb 6;370(6):533-42. doi: 10.1056/NEJMoa1206605.
6
Metabolic myopathies.代谢性肌病。
Curr Rheumatol Rep. 2010 Oct;12(5):386-93. doi: 10.1007/s11926-010-0119-9.